Top Headlines: TaMo To Hike CV Prices; Centre Regrets Nagaland Killings

Tata Motors to hike prices of commercial vehicles from Jan 1

Auto major Tata Motors on Monday said it will hike prices of its commercial vehicles in the range of 2.5 per cent from January 1 to offset the increase in commodity and raw materials costs.

The price hike will be across segments of medium and heavy commercial vehicles (M&HCV), intermediate and light commercial vehicles (I&LCV), small commercial vehicles (SCV) and buses, based on individual model and variant of the vehicle, Tata Motors said in a regulatory filing. Read more

Regret killing of civilians in Nagaland, case of 'mistaken identity': Shah

Expressing regret over the Nagaland firing incident, Home Minister Amit Shah on Monday said that a probe by a Special Investigation Team (SIT) will be completed within a month and asserted that all agencies must ensure such happenings do not recur while taking action against insurgents.

In his statement in Lok Sabha, Shah offered condolences to the families of those killed in the incident on December 4. Read more

China central bank cuts reserve requirement ratio as economy slows

China’s central bank cut the amount of cash most banks must hold in reserve, providing a liquidity boost to a slowing economy facing a worsening property slump and putting China on a clearly different policy trajectory than many other central banks.

The People’s Bank of China will reduce the reserve requirement ratio by 0.5 percentage point for all banks except those that are already on the lowest level of 5%, according to a statement published Monday. The cut will be effective on December 15, according to the statement, which said the weighted average ratio for financial institutions will be 8.4% after the cut. Read more

Next pandemic could be more lethal than Covid, says Oxford vaccine creator

While the Covid-19 crisis is not over yet with the new super mutant Omicron spreading to 38 countries, the next pandemic could be even more lethal, said the creator of the Oxford/AstraZeneca vaccine Professor Sarah Gilbert.

Delivering the 44th Richard Dimbleby Lecture, Gilbert cautioned that it is increasingly obvious that "this pandemic is not done with us", and vaccines could also prove to be less effective against the Omicron variant, the BBC reported. Read more

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor